New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 11, 2013
11:38 EDTBP, DOWFreeport LNG signs 20-year liquefaction tolling agreement with BP
Freeport LNG announced that it had entered into a binding 20-year Liquefaction Tolling Agreement with BP (BP) for 4.4 million tons per annum, equivalent to the production capacity of the second train of Freeport LNG's proposed natural gas liquefaction and LNG loading facility on Quintana Island near Freeport, Texas. The LTA with BP will commence upon completion of construction of the second liquefaction train, Freeport said. Freeport LNG Expansion is a wholly owned subsidiary of Freeport LNG Development, which has four limited partners, including a wholly owned subsidiary of The Dow Chemical Company (DOW).
News For BP;DOW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 27, 2015
05:39 EDTDOWStocks with implied volatility movement; DOW EWZ
Stocks with implied volatility movement; Dow Chemical (DOW) 29, MSCI Brazil Index (EWZ) 41 according to iVolatility.
November 25, 2015
17:42 EDTDOWDow Chemical expects Enlist Duo to be available for the 2016 U.S. crop season
Subscribe for More Information
16:49 EDTDOWOn The Fly: Top stock stories for Wednesday
Stocks began Wednesday in positive territory and remained higher for much of the day before dipping slightly near close. The averages moved in a narrow range as investors digested a host of economic data, including reports on consumer confidence, jobless claims and housing, none of which moved the market in any discernible way ahead of the Thanksgiving holiday. ECONOMIC EVENTS: In the U.S., several days of economic reports were compressed into a single, busy morning. Jobless claims for the week ended November 21 fell to 260,000 against expectations for 270,000 first-time claims. Personal income rose 0.4% in October, matching expectations, while spending rose 0.1% versus estimates for a 0.3% increase. Meanwhile, durable goods orders were up 3% last month versus expectations for up 1.7%. Removing transportation items showed a core reading of up 0.5% against estimates for 0.3%. The FHFA home price index rose 0.8% in September to 226.5, while Markit's services index improved to 56.5 in the flash reading for November, topping the 55.1 forecast. New home sales rose 10.7% to a 495,000 rate in October. Consumer sentiment rose to 91.3 in the final November print of the University of Michigan survey, up from October's 90.0 reading but down from the preliminary November reading of 93.1. COMPANY NEWS: Shares of HP Inc. (HPQ) and HP Enterprise (HPE) headed in opposite directions following the final combined earnings report of the recently-split companies. HP Inc., which was downgraded to Hold at research firm Needham following last night's report, ended the session down 13.63% to $12.65. Meanwhile, HP Enterprise, which also announced a cloud partnership with Microsoft (MSFT), gained 3.14% to $14.12... Deere (DE), which reported better than expected earnings and issued a 2016 sales outlook matching estimates, gained 4.79% to $80 following its quarterly report. MAJOR MOVERS: Among the notable gainers was Tesla (TSLA), which advanced $11.39, or 5.22%, to $229.64 after research firm Credit Suisse reiterated its Outperform rating and $325 price target on the shares, saying the carmaker's January volume report should positively address investor fears over its fourth-quarter performance and Model X production ramp. Also higher was American Capital (ACAS), which gained $1.32, or 9.50%, to $15.22 after expanding its stock buyback program and announcing a strategic review of the company, including a possible sale. Additionally, Veeva (VEEV) jumped 5.01% to $28.73 following its quarterly numbers, which prompted analysts at both JPMorgan and Canaccord to raise their price targets on the stock. Among the noteworthy losers was PTC Therapeutics (PTCT), which declined $2.23, or 7.02%, to $29.52 after Jefferies analyst Gena Wang downgraded the stock to Underperform, saying yesterday's FDA panel for BioMarin's (BMRN) competing muscular dystrophy drug is a negative for PTC. BioMarin, meanwhile, slipped 1.78% to $96.06 for the day, while Sarepta (SRPT), also competing in the same therapeutic space, was up fractionally to $37.49. Also lower were SunEdison (SUNE) and TerraForm Power (TERP), which crashed a respective 21.6% and 17.67% after research firm UBS downgraded both stocks on "considerable" risks suggested by recent management changes at Terraform. TerraForm Global (GLBL), meanwhile, plunged 21.26% to $4.11. Separately, Dow Chemical (DOW) slipped 2.72% to $51.93 after the EPA withdrew approval for the company's Enlist Duo herbicide. INDEXES: The Dow rose 1.20, or 0.01%, to 17,813.39, the Nasdaq gained 13.33, or 0.26%, to 5,116.14, and the S&P 500 slipped 0.27, or 0.01%, to 2,088.87.
11:55 EDTDOWEPA withdraws approval of Dow Enlist Due herbicide, WSJ reports
Subscribe for More Information
11:01 EDTDOWDow Chemical says working to assure EPA of herbacide's safety, DJ reports
Subscribe for More Information
10:47 EDTDOWEPA revokes approval of Dow Enlist Duo herbacide, Dow Jones reports
Subscribe for More Information
November 19, 2015
16:00 EDTDOWOptions Update; November 19, 2015
Subscribe for More Information
08:06 EDTDOWChemours agrees to sell aniline facility to Dow Chemical for $140M
Subscribe for More Information
November 18, 2015
06:01 EDTDOWMonsanto studying possibility for consolidation in agrochem sector, Reuters says
Subscribe for More Information
November 17, 2015
10:16 EDTBPBP confirms exploring sale of Alabama petrochemical facility
BP confirmed that it has decided to market for sale its Decatur, Alabama, petrochemicals complex as part of a broader reorganization of the company's global petrochemicals business. BP said its refocused petrochemicals strategy is pursuing a competitively advantaged portfolio through world-scale, low-cost facilities that utilize BP proprietary technology including the production of purified terephthalic acid, or PTA, a key raw material in the production of polyester. BP is spending $200M to upgrade its Cooper River, S.C., plant and its sister facility in Geel, Belgium - the largest PTA-producing sites in the Americas and Europe, respectively. The investment will enable the two facilities to lower operating costs, improve reliability and reduce emissions. Earlier this year, BP also started up its new Zhuhai 3 unit in Guangdong Province, China. Using BP's latest technology and capable of producing up to 1.25M tons of PTA per year, Zhuhai 3 is the world's largest single-train PTA production unit as well as being one of the largest and most efficient PTA production units in the world. While BP's Decatur complex no longer fits with this strategy, the facility has been a major contributor to BP's U.S. petrochemicals business for many years. It makes chemicals essential for the production of thousands of items, from plastic water bottles to flat-screen televisions. BP expects to complete a sale of all or part of the facility provided a buyer can be found and an acceptable deal can be reached. Reference Link
09:48 EDTBPBP to explore sale of Alabama petrochemical plant, Bloomberg reports
Bloomberg cites e-mailed statement from BP.
November 16, 2015
17:10 EDTDOWSoros took stake in Paypal, liquidated Herbalife stake
Soros Fund Management gave a quarterly update on its stakes in a filing this afternoon. NEW STAKES: Paypal (PYPL), CIT Group (CIT), Schlumberger (SLB), Kraft Heinz (KHC), and Amazon (AMZN). INCREASED STAKES: Allergan (AGN), Lions Gate (LGF), Energen (EGN), Southwest Airlines (LUV), and Qunar Cayman Islands (QUNR). DECREASED STAKES: LyondellBasell (LYB), YPF (YPF), Time Warner Cable (TWC), Dow Chemical (DOW), and Monsanto (MON). LIQUIDATED STAKES: Herbalife (HLF), Lennar (LEN), DR Horton (DHI), United Continental (UAL), and Nice Systems (NICE).
06:51 EDTBPBig energy firms saw 70% earnings dip for first nine months, WSJ says
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use